The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
EuroIntervention 2018;14:789-797 published online July 2018. DOI: 10.4244/EIJ-D-18-00182
Jean-Philippe Collet1, MD, PhD; Mathieu Kerneis1, MD; Benoît Lattuca2, MD; Yan Yan1, MD; Guillaume Cayla2, MD, PhD; Johanne Silvain1, MD, PhD; Frédéric Lapostolle3, MD, PhD; Patrick Ecollan4, MD; Abdourahmane Diallo5, PhD; Eric Vicaut5, MD, PhD; Christian W. Hamm6, MD, PhD; Arnoud W. van ‘t Hof7, MD; Gilles Montalescot1*, MD, PhD; for the ATLANTIC Investigators
1. Sorbonne Université Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière (AP-HP), Paris, France; 2. Department of Cardiology, CHU Caremeau, Université de Montpellier, ACTION Study Group, Nimes, France; 3. SAMU 93 Hôpital Avicenne, Bobigny, France; 4.
Aims: The aim of the study was to examine the main results of the ATLANTIC trial in patients with ST-elevation myocardial infarction (STEMI), randomised to pre- versus in-hospital ticagre